News

Deal Announcements

Lineagen Adds Venture Capital Investment

Thursday, December 19, 2013 5:56:00 AM PDT | VentureDeal
   Salt Lake City, UT  --  Healthcare company Lineagen added $3.5 million in new venture capital equity and debt funding.

Lineagen has developed a platform for testing autism, multiple sclerosis, cancer and chronic obstructive pulmonary disease.

The investor syndicate was led by Signal Peak Ventures and Sanderling Ventures.

Proceeds purposes were not disclosed.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1